The effect of denosumab for the treatment of osteoporosis in hemodialysis patients
Phase of Trial: Phase II
Latest Information Update: 18 Oct 2019
Price : $35 *
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 16 Oct 2019 Status changed from active, no longer recruiting to completed.
- 12 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 11 Jul 2014 New trial record